insights_auto
Kwa nini ABVX imepungua kwa 4.12%?
Fahamu zaidichevron_right
ABVX:EPA
Abivax SA
€ 79.10
arrow_downward
-4.12%(-3.40) Siku 1
13 Nov, 17:35:00 GMT +1 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ABVX...
Fungua
€ 81.25
Juu
€ 82.25
Chini
€ 78.70
Mtaji wa soko
7.01B
Wastani wa kiasi cha mauzo
elfu 109.92
Kiasi cha mauzo ya hisa
elfu 113.83
Juu kwa wiki 52
€ 139.00
Chini kwa wiki 52
€ 60.45
EPS
-€ 5.20
Hisa za wawekezaji
87.55M
Idadi ya wafanyakazi
98
Fungua
€ 81.25
Juu
€ 82.25
Chini
€ 78.70
Mtaji wa soko
7.01B
Wastani wa kiasi cha mauzo
elfu 109.92
Kiasi cha mauzo ya hisa
elfu 113.83
Juu kwa wiki 52
€ 139.00
Chini kwa wiki 52
€ 60.45
EPS
-€ 5.20
Hisa za wawekezaji
87.55M
Idadi ya wafanyakazi
98
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
TradingKey
·
saa 4 zilizopita
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
TradingView
·
saa 10 zilizopita
EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected
24/7 Wall St.
·
saa 6 zilizopita
He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076
Traders Union
·
saa 10 zilizopita
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
Wasifu
Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.
Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated.
The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France. Wikipedia
Kuhusu Abivax SA
Afisa Mkuu Mtendaji (CEO)Marc de Garidel | Hartmut J. Ehrlich
Wafanyakazi98
Lilianzishwa4 Des 2013
Makao makuu-
SektaHealth Care
Sekta-
Tovutiabivax.com